Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-21

Clinical Trial Update: Safety Study of Abatacept to Treat Rheumatoid Arthritis

View source ↗

Summary

A completed safety-focused clinical trial update evaluates abatacept for rheumatoid arthritis, summarizing the trial's safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abatacept (abatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Status: COMPLETED